Metabolism of eicar (5-ethynyl-1-B-dribofurano-sylimidazole-4-carboxamide), a potent inhibitor of inosinate dehydrogenase

Jan Balzarini; L. Stet; Akihiko Matsuda; Leonard I. Wiebe; E. Knauss; De Clercq Erik

doi:10.1016/s0009-9120(97)87643-6

Back

Metabolism of eicar (5-ethynyl-1-B-dribofurano-sylimidazole-4-carboxamide), a potent inhibitor of inosinate dehydrogenase

Article 1997 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1998

Metabolism of Eicar (5-Ethynyl-1-β-D- Ribofuranosylimidazole-4-Carboxamide),A Potent Inhibitor of Inosinate Dehydrogenase

Jan Balzarini, L. Stet, Akira Matsuda, Leonard I. Wiebe, E. Knauss, De Clercq Erik

Article1993

Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.

Jan Balzarini, Anna Karlsson, L Wang, Christina Bohman, K. Horská, Ivan Votruba, Arnold Fridland, Arthur Van Aerschot, Piet Herdewijn, De Clercq Erik

Article1991

Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds

De Clercq Erik, Marina Cools, Jan Balzarini, Robert Snoeck, Graciela Andreï, Mitsuaki Hosoya, Shirô Shigeta, Takuya Ueda, Noriaki Minakawa, Akira Matsuda

Article1996

Synthesis, Conformational Analysis and Biological Evalution of 2-(5-Deoxy-b-D-ribofuranosyl)pyridine-4-carboxamide

Pieter Joos, Alex De Groot, Eddy L. Esmans, F. C. Alderweireldt, André De Bruyn, Jan Balzarini, De Clercq Erik

Article1991

5-(Thien-2-yl)-2′-deoxyuridine: A New and Potent Inhibitor of Herpes Simplex Virus Type 1 Replication

Piet Wigerinck, Arthur Van Aerschot, De Clercq Erik, Piet Herdewijn